Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Rank in Stocks #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Share Price
$88.89
Market Cap
$114.13B
Change (1 day)
-0.93%
Change (1 year)
-2.08%
Country
IE
Trade Medtronic plc (2M6)

Category

Revenue for Medtronic plc (2M6)
Revenue in Jan 2026 TTM: $35.49B
According to Medtronic plc latest financial reports the company's current revenue (TTM) is $35.49B. In 2024 the company made a revenue of $32.36B an increase over the revenue in the year 2023 that was $31.23B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Medtronic plc from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $35.49B 5.83%
2025 $33.54B 3.62%
2024 $32.36B 3.64%
2023 $31.23B -1.45%
2022 $31.69B 5.21%
2021 $30.12B 4.16%
2020 $28.91B -5.38%
2019 $30.56B 2.02%
2018 $29.95B 0.82%
2017 $29.71B 3.04%
2016 $28.83B 42.31%
2015 $20.26B 19.15%
2014 $17.01B 2.50%
2013 $16.59B 2.51%
2012 $16.18B 1.58%
2011 $15.93B 0.73%
2010 $15.82B 8.34%
2009 $14.60B 8.02%
2008 $13.52B 9.89%
2007 $12.30B 8.92%
2006 $11.29B 12.31%
2005 $10.05B 10.65%
2004 $9.09B 18.55%
2003 $7.67B 19.57%
2002 $6.41B 15.47%
2001 $5.55B 10.71%
2000 $5.01B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$44.33B 24.90%
US
$25.12B -29.23%
US
$35.48B -0.02%
IE
$20.08B -43.44%
US
$25.70B -27.60%
DE